newsfilter
← Latest News
GlobeNewswire·

Bioasis Announces Publication Validating its xB³ ™ Platform Technology for CNS Therapeutics

NEW HAVEN, Conn., June 03, 2021 (GLOBE NEWSWIRE) -- BIOASIS TECHNOLOGIES INC. (TSXV:BTI, OTCQB:BIOAF), (the "Company" or "Bioasis"), a pre-clinical, research-stage biopharmaceutical company developing its proprietary xB3 ™ platform technology for the